2023 Tenofovir , Lamivudine, Dolutegravir (TLD2) & Viral Load Done (VLD) Three Interlinked Electronic Registers (Tier.NET) capturing Update

2023 Tenofovir , Lamivudine, Dolutegravir (TLD2) & Viral Load Done (VLD) Three Interlinked Electronic Registers (Tier.NET) capturing Update

2023 Tenofovir , Lamivudine, Dolutegravir (TLD2) & Viral Load Done (VLD) Three Interlinked Electronic Registers (Tier.NET) capturing Update

Objectives: 

South Africa is committed to attaining the UNAIDS 95-95-95 targets to control the HIV epidemic by providing quality healthcare services using highly effective antiretroviral treatment (ART). 

To support the achievement of this goal, the ART clinical guidelines have been updated to include more optimised treatment regimens for children, adolescents and adults, as well as pregnant women living with HIV/AIDS, TB and other common opportunistic infections.

Aim: The goal of this webinar series is to increase awareness regarding capturing of TLD2 and VL in Tier.NET.

Speakers: 

Dr Zamazamela Shelembe 
Medical Practitioner
Qualifications: MBChB (UKZN), PGDip HIV Man(SA), PGCert Advanced Health Management Programme (YALE/FPD)

Mr Matthew Chetty 
Data Analyst
Qualifications: BSc. Computer Science and IT Specialising in Info. & GIs

Date
20 September 2023 - 01:00 pm
until
20 September 2023 - 03:00 pm
CPD points
0
Type
Medical
Topic
HIV/AIDS